Mergers & Acquisitions

TCR2 Therapeutics

03/23
Piper Sandler served as financial advisor for TCR2 Therapeutics Inc. on combination with Adaptimmune Therapeutics
Sub-Type
Merger
Sub-Sector
Biopharma